Campaigners call for stronger rights to work for people living with breast cancer

November 7, 2018, European School of Oncology

Brussels, Belgium: Campaigners are calling on EU parliamentarians to make it easier for people with advanced breast cancer to return to work and to support them properly with flexible working arrangements.

At an event at the European Union Parliament today (Wednesday) hosted by MEP Lieve Wierinck, members of the Advanced Breast Cancer (ABC) Global Alliance highlighted to policy-makers that the financial burden of includes not only the direct cost of treatments, but also the indirect cost from loss of productivity when living with advanced diseases, who are able and willing to continue working, are unable to because of a lack of understanding about their disease or direct or indirect discrimination.

Chair of the ABC Global Alliance, Dr. Fatima Cardoso, of the Champalimaud Clinical Centre in Lisbon (Portugal), said: "Most people with breast are in the most economically productive years of their lives: their 40s, 50s and 60s. Not being able to work is bad for them, not only financially, but also emotionally and psychologically, and it is also bad for society. There are many studies now that show the indirect costs of cancer because of lack of productivity are actually bigger than the direct costs. If these people can continue to work and be productive, it will be much better for society as a whole."

Breast cancer is the most frequently diagnosed cancer worldwide, affecting mainly women but some men too. Over two million new cases of breast cancer will be diagnosed in 2018 and nearly 630,000 people will die from it, almost all from advanced or metastatic disease—cancer that has spread to other parts of the body. Around 6.8 million people are either or currently living with advanced disease, many of whom are capable of, and want to, work.

"Making it difficult or impossible for these people to continue working is resulting in a colossal loss in economic productivity to society," said Dr. Cardoso.

Ms Barbara Wilson, who heads the social enterprise Working with Cancer in the UK, which helps people affected by cancer return to work, told the meeting: "Even for people who are living with the long-term side effects of their treatment, it's perfectly possible for them to continue to work if there are proper strategies in place to support them. This is not about making people return to work, but if someone wants to return, it can, in most cases be managed successfully.

"In order to achieve this, employers need to understand cancer, they need to communicate effectively with employees affected by cancer, and they need to implement flexible working policies during and after treatment, including providing individualised support for those that need it in the form of one-to-one coaching. Too often employers assume either that you should not work and encourage you to leave, or they think that a few weeks after treatment, you'll be fine and then wonder why you are not 'back to normal' as quickly as expected. Neither of these assumptions is helpful; even terminally ill people can sometimes work, nearly up to the time they die, depending on their cancer and the type of work they do."

Ms Wilson and Ms Karen Benn, deputy CEO of Europa Donna, called for all employers to ensure they have training to improve their understanding of cancer and how they communicate with their employees, and they should also have policies that support flexible working. In addition, governments across Europe and, indeed, worldwide, should put in place legislation to make it unlawful for employers to discriminate against people with cancer.

"At the moment some countries have such legislation, while many others don't," said Ms Wilson. "Workplace adjustments often cost tiny amounts compared with the cost of losing a good employee and the cost of recruiting new people."

Ms Benn said: ""It is vital that people living with are not discriminated against in the workplace and policy needs to reflect this."

Professor Richard Sullivan, a surgeon and global cancer policy expert at the Institute of Cancer Policy, King's Health Partners Comprehensive Cancer Centre, King's College London (UK), said not only were there costs to patients, employers and society through loss of productivity when people living with breast cancer found it difficult or impossible to work, but also because of the way cancer treatment and care is managed and funded. He challenged national governments to address the current disconnection between the costs of cancer care and patient outcomes.

"This is a really serious problem." he told the meeting. "We have data that show that the cost of cancer care versus the outcomes for individual patients are completely unconnected. You have countries in Europe that are spending huge amounts on clinical care but are seeing virtually no improvement in outcomes. For instance, Greece is spending a substantial amount on - €34,500 per new case per year—but has seen only minimal improvement in cancer outcomes, whereas other countries have a reduction in the number of deaths of around 20-30%. This all comes down to the governance of cancer care; most countries are just not doing this properly and are paying a lot of money for rubbish care."

He said this was a complex problem that had difficult and uncomfortable solutions. "A lot of countries across Europe are losing the battle in delivering affordable, equitable, high quality care. Governments need to have ruthless pricing and reimbursement control through a transparent mechanism that relates cost to patient outcomes, and that also relates to what is happening in the real world, not just in super centres of clinical excellence. In addition, there needs to be proper governance of clinical care and pathways, so that all patients receive the correct care at the right stage on their cancer journey.

"Some of this is a system problem because we have mixed models of private and public sectors, each gaming each other. Some of it is due to clinical failure and corruption. In other areas it's because the system hasn't put in place proper pricing mechanisms. But all we're seeing at the moment is greater amounts of money being paid for fewer returns in terms of better, more equitable outcomes."

At present, the EU Parliament is looking at proposals for a new directive on work-life balance, which will include provision for leave from work for people caring for children or seriously ill relatives. ABC Global Alliance members are asking them to look at the working rights of cancer patients as well.

Explore further: Drugs for treating breast cancer in women are effective and well tolerated in men

Related Stories

Drugs for treating breast cancer in women are effective and well tolerated in men

October 22, 2018
There is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the largest real-life study yet to investigate treatment and outcomes in ...

Breast cancer patients prefer knowing costs prior to starting treatment

September 25, 2018
Even when they had good health insurance coverage, women with breast cancer reported having financial worries related to their care, and the vast majority said they preferred to know about treatment costs at the time of diagnosis.

Older breast cancer patients in England less likely to survive

June 6, 2018
Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands according to research published today in the British Journal of Cancer.

AHA: breast cancer patients at increased risk for CV disease

February 1, 2018
(HealthDay)—Due to shared risk factors and impact on heart health from cancer treatment, comprehensive care is necessary for breast cancer patients to optimize both cancer treatment and cardiovascular health, according ...

Medicines for breast cancer: The affordability controversy

November 5, 2015
New and better drugs to treat diseases such as advanced breast cancer will have little effect on improving patient outcomes if a country does not have good healthcare structures in place, Professor Richard Sullivan told the ...

Discovery of potential treatment for aggressive form of breast cancer

November 2, 2016
A new drug could be used to treat one of the most aggressive forms of breast cancer, a research centre based at University College Dublin and St Vincent's Hospital has discovered.

Recommended for you

Researchers identify a mechanism that fuels cancer cells' growth

November 14, 2018
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes ...

A new approach to detecting cancer earlier from blood tests: study

November 14, 2018
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined "liquid biopsy", epigenetic alterations and machine learning to develop a blood test to detect and classify ...

New antibody breakthrough to lead the fight against cancer

November 14, 2018
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system.

Photoacoustic imaging may help doctors detect ovarian tumors earlier

November 14, 2018
Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University in St. Louis has found an innovative way to use sound ...

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.